Ethopharmacological analysis of behaviour of rats using variations of the elevated plus-maze

Behavioural Pharmacology

Volumn 8, Issue 6-7, 1997, Pages 533-540

  Anseloni, V Z ^a   Brandao M L ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Elevated plus maze; Ethological analysis; Midazolam; Pentylenetetrazol; Rat; Transparent walls

Indexed keywords

MIDAZOLAM; PENTETRAZOLE; PSYCHOTROPIC AGENT;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; ETHOLOGY; EXPLORATORY BEHAVIOR; FACTORIAL ANALYSIS; GROOMING; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PSYCHOPHARMACOLOGY; RAT; SCINTISCANNING;

EID: 0030735649     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-199711000-00011     Document Type: Article

References (32)

1. Adamec RE and Shallow T (1993) Lasting effects on rodent anxiety of a single exposure to a cat. Physiology and Behavior, 54, 101-109.
2. Anseloni VCZ, Motta V, Lima G and Brandão ML (1995) Behavioral and pharmacological validation of the elevated plus maze constructed with transparent walls. Brazilian Journal of Medical and Biological Research, 28, 597-601.
3. Archer J (1973) Tests for emotionality in rats and mice: a review. Animal Behavior, 21, 205-235.
4. Blanchard DC, Blanchard RJ and Rodgers RJ (1991) Risk assessment and animal models of anxiety. In: Animals Models in Psychopharmacology (Eds B Olivier, J Mos and JL Slangen), pp. 117-134, Birkhauser, Bale.
5. Brandão ML, DiScala G, Bouchet MJ and Schmitt P (1986) Escape behavior produced by the blockade of glutamic acid decarboxylase (GAD) in mesencephalic central gray and medial hypothalamus. Pharmacology, Biochemistry and Behavior, 24, 497-501.
6. Chopin P and Briley M (1987) Animal models of anxiety: the effect of compounds that modify 5-HT neurotransmission. Trends in Pharmacological Sciences, 8, 383-388.
7. Cole JC and Rodgers RJ (1993). An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro-6028) in the murine elevated plus-maze. Behavioural Pharmacology, 4, 573-580.
8. Cole JC and Rodgers RJ (1994) Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol. Psychopharmacology, 14, 288-296.
9. Cruz APM, Frei F and Graeff FG (1994) Ethopharmacological analysis of rat behavior on the plus-maze. Pharmacology, Biochemistry and Behavior, 49, 171-176.
10. Dorow R, Horowski R, Paschelke G, Amin M and Braestrup C (1983) Severe anxiety induced by FG 7142, a β-carboline for benzodiazepine receptors. Lancet, 9, 98-99.
11. Fernandes C and File S (1996) The influence of open arm ledges and maze experience in the elevated plus-maze. Pharmacology, Biochemistry and Behavior, 54, 31-40.
12. File SE (1980) The use of social interactions as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. Journal of Neuroscience Methods, 2, 219-238.
13. File SE (1992) Behavioural detection of anxiolytic action. In: Experimental approaches to anxiety and depression (Eds JM Elliot, DJ Heal and CA Marsden), pp. 25-44. John Wiley and Sons Ltd, Chichester.
14. Green S (1991) Benzodiazepines, putative anxiolytics and animal models of anxiety. Trends in Pharmacological Sciences, 14, 101-104.
15. Griebel G, Moreau J-L, Jenck F, Martin JR and Misslin R (1993). Some critical determinants of the behaviour of rats in the elevated plus-maze. Behavioural Processes, 29, 37-48.
16. Handley SL and McBlane JW (1993) 5-HT drugs in animal models of anxiety. Psychopharmacology, 112, 13-20.
17. Handley SL and Mithani S (1984) Effects of alpha-adrenoceptor agonists in a maze-exploration model of "fear"-motivated behavior. Naunyn-Schmiedeberg's Archives of Pharmacology, 327, 1-5.
18. Kim J and Muller CW (1978) Factor Analysis, Statistical Methods and Practical Issues, pp. 49-54. Sage Publications, California.
19. Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berlin), 92, 180-185.
20. 1A receptor activation on the anxiogenic effects induced by isolation in the elevated plus-maze. Physiology and Behavior, 54, 753-758.
21. Montgomery KC (1955) The relationship between fear induced by novel stimulation and exploratory behaviour. Journal of Comparative and Physiological Psychology, 48, 254-260.
22. Morato de Carvalho S and Castrechini P (1989) Effects of floor and environmental activity in the elevated plus-maze. Brazilian Journal of Medical and Biological Research, 22, 707-710.
23. Moser PC (1989) An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone. Psychopharmacology, 99, 48-53.
24. 1A receptors on the exploratory activity of rats in the elevated plus-maze. Psychopharmacology (Berlin), 107, 135-139.
25. Pellow S and File SE (1986) Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacology, Biochemistry and Behavior, 24, 525-529.
26. Pellow S, Chopin P, File SE and Briley M (1985) Validation of open:closed arm entries in the elevated plus-maze as a measure of anxiety in the rat. Journal of Neuroscience Methods, 14, 149-167.
27. Rodgers RJ and Cole JC (1994) The elevated plus-maze: pharmacology, methodology and ethology. In: Ethology and Psychopharmacology (Eds SJ Cooper and CA Hendrie), pp. 10-44. John Wiley and Sons, Chichester.
28. Rodgers RJ and Johnson NJT (1995) Factor analysis of spatio-temporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacology, Biochemistry and Behavior, 52, 297-303.
29. Scholfield CN (1992) Antagonism of γ-aminobutyric acid and muscimol by picrotoxin, bicuculline, strychnine, bemegride, leptazol, D-tubocurarine and theophylline in the isolated olfactory cortex. Archives of Pharmacology, 318, 274-280.
30. Treit D and Fundytus M (1988) Thigmotaxis as a test for anxiolytic activity in rats. Pharmacology, Biochemistry and Behavior, 31, 958-962.
31. Treit D, Menard J and Royan C (1993) Anxiogenic stimuli in the elevated plus-maze. Pharmacology, Biochemistry and Behavior, 44, 463-469.
32. Trullas R, Winslow TR, Insel TR and Skolnick P (1991) Are glutamatergic pathways involved in the pathophysiology of anxiety? In: New Concepts in Anxiety (Eds M Briley and SE File), pp. 382-394. MacMillan, London.